MedTrace Logo

Exercise to Slow Cardiovascular Ageing Progression

NCT05775484 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 450

Last updated 2025-06-05

No results posted yet for this study

Summary

In ageing, deleterious alterations in cardiovascular (CV) structure and function increase risks of ageing-related cardiovascular disease (CVD). Investigators found that these CV alterations were associated with circulating serum metabolites, suggesting a metabolic basis to CV ageing. Investigators hypothesize that modification of these metabolites by intervention, such as exercise, may retard CV alterations and reduce CVD in ageing.

Conditions

Sponsors & Collaborators

  • National Heart Centre Singapore

    lead OTHER

Eligibility

Min Age
21 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-05-01
Primary Completion
2026-12-31
Completion
2050-12-31

Countries

  • Singapore

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05775484 on ClinicalTrials.gov